# Determining the Impact of Penicillin in Latent RHD: The GOAL Trial

> **NCT03346525** · PHASE2 · UNKNOWN · sponsor: **Children's National Research Institute** · enrollment: 807 (actual)

## Conditions studied

- Rheumatic Heart Disease in Children
- Latent Rheumatic Heart Disease
- Rheumatic Heart Disease
- Heart Diseases

## Interventions

- **DRUG:** intramuscular benzathine penicillin G (BPG) prophylaxis

## Key facts

- **NCT ID:** NCT03346525
- **Lead sponsor:** Children's National Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-26
- **Primary completion:** 2020-11-30
- **Final completion:** 2020-11-30
- **Target enrollment:** 807 (ACTUAL)
- **Last updated:** 2019-10-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03346525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03346525, "Determining the Impact of Penicillin in Latent RHD: The GOAL Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03346525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*